XZ

Xiaozhang Zheng

FT Forma Therapeutics: 43 patents #3 of 86Top 4%
VH Valo Health: 18 patents #1 of 53Top 2%
KT Kymera Therapeutics: 10 patents #6 of 23Top 30%
NE Neurogen: 10 patents #25 of 120Top 25%
Genentech: 10 patents #288 of 2,392Top 15%
FT Forma Tm: 9 patents #1 of 24Top 5%
VD Valo Early Discovery: 8 patents #3 of 30Top 10%
NA Novo Nordisk Health Care Ag: 4 patents #16 of 131Top 15%
HI H. Lee Moffitt Cancer Center And Research Institute: 1 patents #146 of 269Top 55%
Pfizer: 1 patents #3,022 of 5,153Top 60%
📍 Lexington, MA: #16 of 2,299 inventorsTop 1%
🗺 Massachusetts: #223 of 88,656 inventorsTop 1%
Overall (All Time): #13,065 of 4,157,543Top 1%
105
Patents All Time

Issued Patents All Time

Showing 51–75 of 105 patents

Patent #TitleCo-InventorsDate
10555935 2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors Pui Yee Ng, Mary-Margaret Zablocki 2020-02-11
10538496 Methods using HDAC11 inhibitors Jennifer Lee, Pearlie Burnette, Srikumar Chellappan, Nicholas Barczak, Jaime Escobedo +8 more 2020-01-21
10513501 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-12-24
10508088 Methods using HDAC11 inhibitors Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, Bingsong Han +6 more 2019-12-17
10508077 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, Bingsong Han, David R. Lancia, Jr., Cuixian Liu +5 more 2019-12-17
10501424 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-10
10494354 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-03
10494353 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-03
10494352 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-03
10494351 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-12-03
10479772 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-11-19
10472337 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-11-12
10472371 Compositions for activating pyruvate kinase Neal Green, Gary Gustafson, David R. Lancia, Jr., Lorna Helen Mitchell, Tatiana Shelekhin 2019-11-12
10464909 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-11-05
10464910 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-11-05
10456382 Compounds and compositions for the inhibition of NAMPT Kenneth W. Bair, Timm R. Baumeister, Alexandre Joseph Buckmelter, Karl H. Clodfelter, Peter Dragovich +8 more 2019-10-29
10457652 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-10-29
10450283 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-10-22
10450284 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +4 more 2019-10-22
10442776 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-10-15
10428031 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-10-01
10421731 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-09-24
10421732 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +6 more 2019-09-24
10414738 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki, Cuixian Liu +5 more 2019-09-17
10407418 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors Pui Yee Ng, Aleksandra Rudnitskaya, David R. Lancia, Jr. 2019-09-10